Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

Clinical trial NCT07405190 · RECRUITING

Trial details

NCT number: NCT07405190
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer (NSCLC)Lung Cancer Non-Small Cell Cancer (NSCLC)Lung Cancer (Non-Small Cell)Lung Cancer - Non Small Cell Lung Cancer Non Small Cell Genomic Alterations

Start date: 2026-05-01
Primary completion: 2028-03-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.